Skip to content

Autostat II Anti-TPO

by Cogent Diagnotics, Ltd.

510(k) K943580

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK943580 Date17 Apr 1995ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
JNL
FDA applicant
Cogent Diagnotics , Ltd.
Device Class
Class II
Regulation
21 CFR Part 866.5870
Advisory Committee
Immunology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 21 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Autostat II Anti-TPO is an immunochemical device used for the detection of thyroglobulin autoantibodies. It functions as an in vitro diagnostic tool within the field of immunology.

This device is manufactured by Cogent Diagnostics, Ltd. and has received FDA 510(k) clearance. It is classified as a Class II medical device under regulation number 866.5870.

Other devices from Cogent Diagnotics, Ltd.

See all devices from Cogent Diagnotics, Ltd. →

Questions

AI-generated answers, 21 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary function of the Autostat II Anti-TPO?

    The Autostat II Anti-TPO is an in vitro diagnostic tool designed specifically for the detection of thyroglobulin autoantibodies. It operates within the field of immunology to assist in clinical laboratory testing.

  • What is the regulatory classification of this device?

    The Autostat II Anti-TPO is classified as a Class II medical device under regulation number 866.5870. It has received FDA 510(k) clearance, confirming it as substantially equivalent to other legally marketed devices.

  • Who is the manufacturer of the Autostat II Anti-TPO?

    This device is manufactured by Cogent Diagnostics, Ltd., located in Edinburgh, United Kingdom. The company is the applicant responsible for the device's FDA 510(k) clearance under K943580.